Longevity Guru Peter Attia Exits David Protein and Personal Startup Amid Epstein Ties – Silence from Involved Parties

In a surprising development, Peter Attia, the renowned longevity expert with past links to Jeffrey Epstein, has reportedly left his positions at David Protein and his own startup.

Sources close to the matter indicate that Attia's departure comes without any official statement, fueling speculation in the health and tech communities.

Background on Peter Attia's Career

Attia, a physician and podcaster, gained fame for his work in longevity medicine, authoring bestsellers and advising high-profile clients.

His association with Epstein, revealed through public records, has long cast a shadow over his professional endeavors.

Details of the Departure

According to the original TechCrunch report, Attia severed ties with David Protein, a biotech firm focused on protein-based therapies, and his unnamed personal venture.

No reasons were provided for the exits, and representatives from both entities declined to comment when approached.

Historical Context and Epstein Connections

Attia's Epstein links stem from investments and associations dating back years, which have periodically resurfaced in media scrutiny.

Despite this, Attia built a successful brand around health optimization, including his popular podcast The Drive.

Potential Impact on the Longevity Industry

This move could signal shifts in the burgeoning longevity sector, where ethical concerns increasingly influence partnerships.

Industry analysts predict that Attia's departure might affect investor confidence in related startups.

Future Implications and Speculations

Looking ahead, Attia may pivot to independent projects, but the lack of commentary leaves room for ongoing rumors.

Observers note that this event underscores the importance of transparency in biotech and health innovation fields.